{"title":"Evaluation of Oral Clarithromycin in the Treatment of Cutaneous Leishmaniasis in Moroccan Children: A Series of 64 Patients.","authors":"Fatima Ezzahraa Chekairi, Bouchra Baghad, Zineb Mouhsine, Fatima Zahra Elfatoiki, Imane El Idrissi Saik, Maha Soussi Abdallaoui, Soumiya Chiheb, Myriam Riyad","doi":"10.1111/pde.15890","DOIUrl":null,"url":null,"abstract":"<p><p>Cutaneous leishmaniasis (CL) is commonly seen in pediatric patients in endemic areas, including Morocco. This retrospective, single center study details 64 confirmed pediatric cases of CL treated with oral clarithromycin 15 mg/kg/day for 10 days per month, for a total of three months. Lesions improved in 96.8% of cases and the treatment was well tolerated. Clarithromycin seems a safe and effective alternative to intralesional injections of meglumine antimoniate.</p>","PeriodicalId":19819,"journal":{"name":"Pediatric Dermatology","volume":" ","pages":""},"PeriodicalIF":1.2000,"publicationDate":"2025-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Dermatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/pde.15890","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Cutaneous leishmaniasis (CL) is commonly seen in pediatric patients in endemic areas, including Morocco. This retrospective, single center study details 64 confirmed pediatric cases of CL treated with oral clarithromycin 15 mg/kg/day for 10 days per month, for a total of three months. Lesions improved in 96.8% of cases and the treatment was well tolerated. Clarithromycin seems a safe and effective alternative to intralesional injections of meglumine antimoniate.
期刊介绍:
Pediatric Dermatology answers the need for new ideas and strategies for today''s pediatrician or dermatologist. As a teaching vehicle, the Journal is still unsurpassed and it will continue to present the latest on topics such as hemangiomas, atopic dermatitis, rare and unusual presentations of childhood diseases, neonatal medicine, and therapeutic advances. As important progress is made in any area involving infants and children, Pediatric Dermatology is there to publish the findings.